BINDING OF ANTIPARKINSONIAN ERGOT DERIVATIVES TO THE DOPAMINE RECEPTOR

被引：13

作者：

WEIR, RL ^{[1
]}

HRUSKA, RE ^{[1
]}

SILBERGELD, EK ^{[1
]}

机构：

[1] HOWARD UNIV,DEPT NEUROL,WASHINGTON,DC 20060

来源：

PSYCHOPHARMACOLOGY | 1981年 / 75卷 / 02期

关键词：

D O I：

10.1007/BF00432172

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：119 / 123

页数：5

共 25 条

[1]

AELLIG WH, 1977, INT J CLIN PHARM BI, V15, P106

[2] EVIDENCE FOR AN IRREVERSIBLE INTERACTION OF BROMOCRYPTINE WITH CENTRAL DOPAMINE-RECEPTORS [J].

BANNON, MJ ;

GRACE, AA ;

BUNNEY, BS ;

ROTH, RH .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (01) :37-41

[3]

BANNON MJ, 1979, NEUR ABSTR, V5, P329

[4] GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE [J].

BESSER, GM ;

MCNEILLY, AS ;

EDWARDS, CRW ;

PARKE, L ;

FORSYTH, IA .

BRITISH MEDICAL JOURNAL, 1972, 3 (5828) :669-&

[5]

CALNE DB, 1974, LANCET, V2, P1355

[6]

FUXE K, 1978, FEDN P, V37, P2182

[7]

GOLDSTEIN M, 1978, FED PROC, V37, P2202

[8]

GOLDSTEIN M, 1979, INT S ERGOT ALKALOID, P12

[9] STUDIES IN-VIVO ON RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5-HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L-TRYPTOPHAN [J].

GRAHAMESMITH, DG .

JOURNAL OF NEUROCHEMISTRY, 1971, 18 (06) :1053-+

[10]

HERMANN WM, 1977, HEADACHE, V17, P54

← 1 2 3 →